Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Circadin® to Alleviate Sleep Disturbances in Children With Neurodevelopmental Disabilities
Conditions
Interventions
Circadin 2/5/10 mg
Placebo
Locations
28
United States
Southwest Autism Research and Resource Center (SARRC)
Phoenix, Arizona, United States
Crystal BioMedical Research, LLC
Miami Lakes, Florida, United States
Lake Mary Pediatrics
Orange City, Florida, United States
Mate Lazlo
West Palm Beach, Florida, United States
Attalla Consultants LLC, dba Institue for Behabiovral medicine
Smyrna, Georgia, United States
AMR Baber research INC
Naperville, Illinois, United States
Start Date
October 1, 2013
Primary Completion Date
March 27, 2018
Completion Date
March 27, 2018
Last Updated
April 23, 2024
NCT07426991
NCT07168577
NCT07299578
NCT06941948
NCT06473415
NCT05565833
Lead Sponsor
Neurim Pharmaceuticals Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions